
Esomeprazole Injection
| Product/Composition | Esomeprazole Injection |
|---|---|
| Strength | 40mg |
| Form | Injection |
| Production Capacity | 1 Million Injection/Month |
| Therapeutic use | GIT Medicine |
| Package Insert/Leaflet | Available upon request |
Esomeprazole Injection
-
Type: Acid-reducing medication
-
Drug Class: Proton Pump Inhibitor (PPI)
-
Form: Lyophilized powder or solution for intravenous (IV) injection or infusion
How It Works
-
Esomeprazole selectively inhibits the H⁺/K⁺ ATPase enzyme (proton pump) in the stomach lining.
-
This blocks the final step of gastric acid secretion, reducing stomach acid production regardless of stimulus (food, histamine, gastrin).
-
IV administration allows rapid acid suppression, which is useful when oral intake is not possible.
Common Uses
Esomeprazole injection is generally used for:
-
Acute treatment of gastric or duodenal ulcers, especially those associated with upper GI bleeding
-
Prevention of rebleeding after endoscopic treatment of peptic ulcers
-
Severe gastroesophageal reflux disease (GERD) when oral therapy is not feasible
-
Stress ulcer prophylaxis in critically ill patients
-
Treatment of Zollinger–Ellison syndrome (severe acid hypersecretion disorder) when oral therapy is not an option
Advantages
-
Works quickly to control stomach acid production
-
Suitable for patients who cannot swallow pills or are on nil per oral (NPO) status
-
Reduces risk of rebleeding in high-risk ulcer patients
-
Once stabilized, patients can be switched to oral PPI therapy
Possible Side Effects
Common:
-
Headache
-
Diarrhea or constipation
-
Nausea
-
Abdominal discomfort
Less Common but Serious:
-
Low magnesium levels (with prolonged use)
-
Rare allergic reactions (rash, swelling, breathing difficulty)
-
Very rarely, kidney inflammation (interstitial nephritis)
-
Risk of Clostridioides difficile infection with long-term use
Precautions
-
Use with caution in patients with severe liver disease (dose adjustment may be needed)
-
Long-term use should be monitored for risks like vitamin B12 deficiency or bone fractures
-
Should not be mixed with other IV medications in the same line unless compatibility is confirmed
-
Stop IV once the patient can tolerate oral medication and switch to oral PPI